Transcript SOLOMON Islands Poster 2008 - Secretariat of the Pacific Community

Solomon Islands
National TB Program
Mr. Noel Itogo
National TB/Leprosy Coordinator
Mr. Paul Mauruwai
Medical Laboratory Technician
Fourth Pacific Stop TB Meeting
11 – 14 March 2008, Brisbane
Country Information (2007)
Population
Appox.500,000
DOTS coverage
100%
MDR-TB in new cases
Nil
MDR-TB in previous treated TB cases
nil
HIV prevalence
10
HIV – among new adult TB cases
Nil
Notification of cases, all forms &
smear +ve cases 2000 - 2007
396
397
400
371
350
340
293
300 302 292
256
250
Number of
200
cases
169
152
150
142
138
124
118
109
108
100
50
0
2000 2001 2002 2003 2004 2005 2006 2007
All forms
Smear +ve cases
Per 100,000 pop
Trend of notification rates: 2000 – 2007
(all forms of TB & new smear +ve cases
90
80
70
60
50
40
30
20
10
0
72
73
68
58
26
2000
28
2001
24
2002
82
75
77
25
26
64
33
30
2003
2004
Smear +ve cases
35
2005
All forms
2006
2007
Trend of cure & TSR
2000 - 2006
110
100
90
80
70
% 60
50
40
30
20
10
0
92.1
92.1
92.6
90
68.4
68.4
71.3
68
2000
2001
2002
2003
97.2
84
58
2004
Years
TSR
Cure
89
73
53
2005
2006
Anti-TB drug supply





Previously TB drugs were purchased from
- Bouchir & Moir – Aust
- Moltichem Export Ltd – NZ
Now we get our drugs from GDF
All drugs including TB were purchased under Aus Aide & SIG
funding
We did experience minor drug shortage last year due to the
change from single formulation to FDC and delay in receiving
the FDC drugs
We have just received our FDC drugs from GDF and have
started distribution to provinces
Laboratory Workload Reports
Q1 - 2007
Q2 - 2007
Q3 - 2007
Q4 - 2007
Patients
tested
+ve
tested
+ve
tested
+ve
tested
+ve
Diagnosis
129
18
190
16
209
15
162
20
Follow-up
27
5
34
4
21
1
33
9
Not stated
11
0
4
0
9
0
2
0
Diagnosis
330
39
479
40
449
36
517
45
Follow-up
55
7
63
7
61
1
74
16
Not stated
27
0
9
0
20
0
6
0
Specimens
Laboratory Quality Assurance
Proportion of specimens scored as saliva
30%
Are ZN staining reagents prepared in the local TB laboratory?
Yes/No
Yes
Are control slides used to check performance of ZN stain?
No
Was there any shortage of laboratory supplies during the past year? (Yes/No)
Yes
Proportion of AFB microscopy results available within 24hrs (% of total)
80%
Did your lab(s) participate in a panel test during the past year? (Yes/No)
yes
Did your lab(s) participate in blinded rechecking during the past year? (Yes/No)
yes
Were on-site evaluations carried out of laboratory services since Aug 2006? (Yes/No)
yes
Indicators of QA Implementation
(1) Total number of TB microscope Units
9
(2) Having had at least one round of blindedrechecking (EQA) in 2007:
3/9
33%
(3) With poor performance (major errors)
determined during the last round of EQA
0
0%
(4) Where corrective action was taken if poor
performance found during last EQA
0
0%
2006 Country action plan







TB Strategic Plan 2006-2010 developed
TB/HIV Collaboration policy developed
EQA and cross checking program re-established
Drug procurement through GDF implemented and supply
improved
Continuous training of health workers on DOTS continued
Continue to provide community awareness programs on high
prevalence areas
Continue to implement Global Fund supported activities
Funding for TB
Source(s)
SIG Grant
GFATM
WHO
Duration
Jan – Dec 2008
Jan – June 2008
Jan – Dec 2009
Total available
Estimated financial gap for…………
Amount
SBD$100,000.00
- NK
- NK
Achievements





TB/HIV Collaboration policy developed
Drug procurement through GDF established and
drug supply improved
Training workshop for nurses on FDC conducted
New National TB/Laboratory coordinator has just
been appointed
Program Review and planning workshop for
Provincial TB Coordinators & Lab technicians
conducted
Weaknesses








Inadequate financial support from Govt.
Shortage of TB drugs during transition period
Frequent changes of program officers
Untimely reporting from provinces
EQA not done effectively due to no full time staff
Infrastructure limitations - Inadequate space in
most labs
Frequent shortage of laboratory supplies e.g ZN
stains, slides
No funds for specimen/smear referrals
Stock levels and estimation of
drug requirements
Category
Regimen used in the country
Total number of cases in the
most recent year(2007)
1
2HRZE/4HR
368 cases
2
2HRZES/1HRZE/5HRE
9 cases
3
2HRZ/4HR
20 cases
1&3
Current stock levels as on 05/03/08
(A)
Drugs needs
for 1 year
(B)
Drugs needs
per month
(A/12)
(C)
Current
stock of
drugs
(D)
Stock available
in months
(C/B)
(E)
Pending
deliveries
(If any)
Kits Cat 1& 3
405
33
810
24
405
Kits Cat 2
15
1
30
30
15
HRZE
150/75/400/276
70,560
5880
141,120
24
70,560
HRE
150/75/400/275
6300
525
12,600
24
6300
RH
150/75
136,080
11340
272,160
24
136080
RH
150/150
-
-
-
-
-
EH
400/150
-
-
-
-
-
Drugs
Stock level con’t
(A)**
Drug needs
for 1 year
(B)
Drug needs
per month
(A/12)
(C)
Current stock
of drugs
(D)
Stock
available in
months (C/B)
(E)
Pending
deliveries
(if any)
Z400
1680
-
-
-
-
E400
1120
210
95,760
456
95,760
H300
-
-
-
-
-
Streptomycin 1g
504
42
1680
40
1680
Water for
injection
504
42
1680
40
1680
Hypodermic
syringe
504
42
1680
40
1680
Drugs
Hypodermic
syringe (AD)*
Add items as
necessary